Companies · Other Health Care

Specialists On Call, Inc.

RESTON · Other Health Care

Diligence memoA one-page analyst read on Specialists On Call, Inc. — recommendation, valuation, rhythm, risks.
$131.7M
Total raised · real
10
Rounds
0.1×
Latest step-up
Top 4%
Sector rank · raised
Series B
Latest stage · inferred · Mon Dec 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Specialists On Call, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.12× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Specialists On Call, Inc. is one of 5377 Other Health Care companies tracked from RESTON. By capital raised it ranks among the largest (ahead of 97% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2019-12-09
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2008-04-01 Raised $6.9M (real) Modeled valuation $139M (est)Series A2008Series A · 2009-05-28 Raised $4.8M (real) Modeled valuation $98M (est)Series A2009Series A · 2010-12-16 Raised $6.3M (real) Modeled valuation $127M (est)Series A2010Series A · 2012-03-05 Raised $2.0M (real) Modeled valuation $40M (est)Series A2012Series A · 2013-06-07 Raised $5.0M (real) Modeled valuation $101M (est)Series A2013Series B · 2014-01-23 Raised $32M (real) Modeled valuation $700M (est)Series B2014Series B · 2014-01-23 Raised $32M (real) Modeled valuation $700M (est)Series B2014Series B · 2014-11-12 Raised $40M (real) Modeled valuation $881M (est)Series B2014Series A · 2015-08-07 Raised $15M (real) Modeled valuation $302M (est)Series A2015Series B · 2015-08-07 Raised $20M (real) Modeled valuation $443M (est)Series B2015Series B · 2017-12-11 Raised $13M (real) Modeled valuation $295M (est)Series B2017Series B · 2019-12-09 Raised $2.0M (real) Modeled valuation $44M (est)Series B2019Cumulative $178M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.9M · 2008
Series A extension$4.8M · 2009
Series A extension$6.3M · 2010
Series A extension$2.0M · 2012
Series A extension$5.0M · 2013
Series B$31.6M · 2014
Series B extension$31.6M · 2014
Series B extension$39.8M · 2014
Bridge · Series B-stage$15.0M · 2015smaller follow-on
Series B extension$20.0M · 2015
Series B extension$13.3M · 2017
Series B extension$2.0M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$44.3M
Base estimate est.
$4.7M
Conservative case
$170.5M
Upside case
$11.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $138.9M · 2008-04-012008Series A · modeled $97.9M · 2009-05-28Series A · modeled $126.8M · 2010-12-16Series A · modeled $40.4M · 2012-03-05Series A · modeled $100.9M · 2013-06-07Series B · modeled $700.3M · 2014-01-23Series B · modeled $700.3M · 2014-01-23Series B · modeled $881.0M · 2014-11-12Series A · modeled $302.3M · 2015-08-07Series B · modeled $443.1M · 2015-08-07Series B · modeled $295.4M · 2017-12-11Series B · modeled $44.3M · 2019-12-092019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
6.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$11.3M/yr
Capital velocity
18.3 yr
On record since
2008
First round
12
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 54× above median
This company$131.7M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.1× of median
This company$2.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 2.0× above median
This company$44.3M
Sector median$22.1M

Raised more than 97% of sector peers (real $). Modeled value above 65% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #71 of 78.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $757.1M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)National Spine & Pain Centers Holdings, LLC · Series B Raised $32.0M · modeled $708.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $621.4M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)Specialists On Call, Inc. (this company) Raised $131.7M · modeled $44.3M (est)Specialists On Call, Inc.
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.36×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$757.1M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLCSeries B$32.0M$708.9M1.89×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.86×
Lotus Parent, Inc.Series B$31.2M$690.4M1.84×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$621.4M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
Specialists On Call, Inc. this companySeries B$131.7M$44.3M0.12×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.9M2008-04-01$31.3M$138.9M85%
Series A$4.8M2009-05-28$22.0M$97.9M85%
Series A$6.3M2010-12-16$28.6M$126.8M85%
Series A$2.0M2012-03-05$9.1M$40.4M85%
Series A$5.0M2013-06-07$22.7M$100.9M85%
Series B$31.6M2014-01-23$175.6M$700.3M85%
Series B$31.6M2014-01-23$175.6M$700.3M85%
Series B$39.8M2014-11-12$220.9M$881.0M85%
Series A$15.0M2015-08-07$68.1M$302.3M85%
Series B$20.0M2015-08-07$111.1M$443.1M85%
Series B$13.3M2017-12-11$74.1M$295.4M90%
Series B$2.0M2019-12-09$11.1M$44.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.9M2008-04-01
    • First recorded raise — entered as Series A.
    • 56 investors on this round.
  2. Series A$4.8M2009-05-28
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 32 investors on this round.
  3. Series A$6.3M2010-12-16
    • Raised 19 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 6 investors on this round.
  4. Series A$2.0M2012-03-05
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 3.1× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  5. Series A$5.0M2013-06-07
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 54 investors on this round.
  6. Series B$31.6M2014-01-23
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 6.3× larger than the prior — scaling up.
    • 7 investors on this round.
  7. Series B$31.6M2014-01-23
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 7 investors on this round.
  8. Series B$39.8M2014-11-12
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 26 investors on this round.
  9. Series A$15.0M2015-08-07
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 2.7× smaller than the prior — bridge or down round.
    • 34 investors on this round.
  10. Series B$20.0M2015-08-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 34 investors on this round.
  11. Series B$13.3M2017-12-11
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 25 investors on this round.
  12. Series B$2.0M2019-12-09
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 6.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~13mo cadence
$2.0M
Modeled next size est.range $2.0M$3.2M
0.1×
Last step-up
$11.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bevil J Hogg4 other2012-03
In Seon Hwang4 other2015-08
Fred Goad3 other2008-04
James Sims2 other2008-04
KEITH MULLINS2 other2008-04
L. KEITH MULLINS2 other2012-03
Art Toscanini1 other2008-04
A. Travis Spitzer1 other2012-03
Fred C. Goad1 other2017-12
Hammad Shah1 other2017-12
Jacqueline B. Kosecoff1 other2013-06
Sean Jason Banerjee1 other2017-12
ALBERTO JASON PE?ALVER2017-12
Amr B. Kronfol2013-06
AMR C. KRONFOL2017-12
Amr Seon Kronfol2015-08
Arthur M. Toscanini2012-03
Bevil Hogg2008-04
B. Tilman Jolly2013-06
David Butterworth2008-04
DAVID C. BLOM2017-12
David Hiatt2008-04
David Tilman Butterworth2013-06
David X. Butterworth2012-03
Registry & provenance

Specialists On Call, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1396565
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Endostim, Inc.Other Health CareSeries A$61.3M$56.7Mnetwork2 shared operators · same sector
Elira, Inc.Other Health CareSeed$14.0M$21.5Mnetwork2 shared operators · same sector
SOC Telemed, Inc.Other Health CareSeries C$103.0M$1.9Bnetwork1 shared operator · same sector
Metabolon, IncOther Health CareSeries B$123.6M$42.1Msame sector · same stage
Remedi SeniorCare Holding CorpOther Health CareSeries D+$342.2M$3.4Bnetwork1 shared operator · same sector
Club Holdings LlcOther TravelSeries C$78.4M$17.3Mnetwork2 shared operators
AccuVein Inc.Other Health CareSeries B$64.0M$53.5Msame sector · same stage
Summus Global, Inc.Other Health CareSeries B$59.3M$35.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Urgent Specialists Management, LLCOther Health CareSeries A$201.8M85%
Innovation Specialists LlcOther Health CareSeed$15.5M85%
Simple Contacts Inc.Other Health CareSeries A$285.5M83%
SOC Telemed, Inc.Other Health CareSeries C$1.9B83%
MedCare Partners, Inc.Other Health CareSeries A$29.4M83%
Specialty Networks, LLCOther Health CareSeries C$2.2B82%
IR-Med, Inc.Other Health CareSeed$37.0M82%
Physician 360, Inc.Other Health CareSeed$17.5M82%
Frequently asked
How much funding has Specialists On Call, Inc. raised?
Specialists On Call, Inc. has raised approximately $131.7M in disclosed capital across 10 recorded financing rounds, aggregated from public filings.
What is Specialists On Call, Inc.'s estimated valuation?
Provath's modeled valuation for Specialists On Call, Inc. is approximately $44.3M (modeled range $4.7M–$170.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Specialists On Call, Inc. at?
Specialists On Call, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Mon Dec 09.
What does Specialists On Call, Inc. do and where is it based?
Specialists On Call, Inc. operates in the Other Health Care sector, based in RESTON.
Explore related

See where Specialists On Call, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Specialists On Call, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.